Page 3 - கண்டறியும் இமேஜிங் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கண்டறியும் இமேஜிங் சேவைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கண்டறியும் இமேஜிங் சேவைகள் Today - Breaking & Trending Today

Morepen Labs betting big on diagnostics devices segment: CMD

Morepen Labs betting big on diagnostics devices segment: CMD
SECTIONS
Last Updated: Apr 25, 2021, 04:07 PM IST
Share
Synopsis
The company is also planning an expansion of its pharmaceutical complex at Baddi in Himachal Pradesh and is looking at an investment of over Rs 178 crore for it.
Reuters
Drug firm
Morepen Laboratories is betting big on the diagnostics devices segment going forward while building its presence in the active pharmaceutical ingredient (API) segment, a top company official said.
The company is also planning an expansion of its pharmaceutical complex at Baddi in Himachal Pradesh and is looking at an investment of over Rs 178 crore for it, he added. ....

Himachal Pradesh , Morepen Laboratories Chairman , Morepen Laboratories , Co Vid , Diagnostics Devices Segment , இமாச்சல் பிரதேஷ் , மேலும் ஆய்வகங்கள் தலைவர் , மேலும் ஆய்வகங்கள் , இணை வித் , பரிசோதனை சாதனங்கள் பிரிவு ,

Impact of proposed law would increase regulatory oversight of certain diagnostic tests

Impact of proposed law would increase regulatory oversight of certain diagnostic tests
Legislation currently under consideration in the U.S. Congress would increase regulatory oversight of certain diagnostic tests, and a new study by researchers at Massachusetts General Hospital (MGH) and colleagues from several other institutions demonstrates that its potential impact will depend on key details in the bill s final language.
This study, published in
JCO Oncology Practice, offers the first evidence-based analysis of how new rules proposed for the regulation of laboratory-developed tests (LDTs) could affect health care costs in the United States.
The idea of having more oversight of LDTs is justified. But our results show that it s very important to align the language in this new law with the intent of what it s trying to accomplish. ....

United States , Jochen Lennerz , Jeff Allen , Richard Huang , Emily Henderson , Us Congress , Drug Administration , Friends Of Cancer Research , Massachusetts General Hospital , Study Senior Author , Medical Director , Integrated Diagnostics , Massachusetts General , Verifying Accurate , Cancer Research , Cancer Treatment , N Vitro , Medical School , ஒன்றுபட்டது மாநிலங்களில் , ஜெஃப் ஆலன் , ரிச்சர்ட் ஹுவாங் , எமிலி ஹென்டர்சன் , எங்களுக்கு காங்கிரஸ் , நண்பர்கள் ஆஃப் புற்றுநோய் ஆராய்ச்சி , மாசசூசெட்ஸ் ஜநரல் மருத்துவமனை , படிப்பு மூத்தவர் நூலாசிரியர் ,

All-in-one test provides a promising solution for COVID-19 detection and mutational surveillance

All-in-one test provides a promising solution for COVID-19 detection and mutational surveillance
A new type of COVID-19 testing strategy could help streamline the process of identifying cases, tracking variants and detecting co-infecting viruses.
At present, separate assays and complex workflows are involved in each of these three diagnostic procedures, with analyses typically performed in highly specialized facilities. KAUST researchers have now combined all three kinds of tests into a single procedure that should allow for point-of-care tracking of COVID-19 and the many emerging variants of SARS-CoV-2.
Our all-in-one test provides a promising integrated solution for rapid field-deployable detection and mutational surveillance of pandemic viruses, says stem cell biologist Mo Li, who led the study. ....

Saudi Arabia , United States , Mo Li , Emily Henderson , Rapid Research Response Team , Smart Health Initiative , Stem Cell , Ars Cov 2 , சவுதி அரேபியா , ஒன்றுபட்டது மாநிலங்களில் , மோ லி , எமிலி ஹென்டர்சன் , விரைவான ஆராய்ச்சி பதில் அணி , தண்டு செல் ,

Spain has performed more than 37.7 million diagnostic tests since the beginning of the pandemic

Spain has performed more than 37.7 million diagnostic tests since the COVID-19 pandemic began. Specifically, the autonomous communities have notified the Ministry of Health that, until April 8, they have carried out a total of 37,755,947 diagnostic tests. Of these, 28,506,257 are PCR and 9,249,690 are antigen tests. In the last week, from April 2 … ....

Ministry Of Health , Health Departments , 37 7 , Co Vid , அமைச்சகம் ஆஃப் ஆரோக்கியம் , ஆரோக்கியம் துறைகள் , இணை வித் , சர்வதேச பரவல் ,

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

Researchers explore an inhalable SARS-CoV-2 nanobody therapy
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the world’s third major coronavirus outbreak. To date, the SARS-CoV-2 has infected over 135 million lives and caused over 2.9 million deaths.
Even as vaccines against SARS-CoV-2 are being developed and administered at an unprecedented pace, treating this infection remains a challenge.
To address this, researchers from China have used nanobodies (Nb) as a possible therapeutic approach. In a recent paper, published in the journal
MedComm, they reported Nb phage display libraries derived from four camels immunized with the SARS-CoV-2 spike RBD. ....

Bio Shutterstock , Ramya Dwivedi , Chinese Academy Of Science , National Virusresource , Wuhan Institute Of Virology , Huen Structure Bio , Wuhan Institute , Chinese Academy , Coronavirus Disease Covid 19 , Sars Cov 2 , Corona Virus , Severe Acute Respiratory , Severe Acute Respiratory Syndrome , ரம்யா டுவிவேடி , சீன கலைக்கழகம் ஆஃப் அறிவியல் , சீன கலைக்கழகம் , கொரோனா வைரஸ் , சர்வதேச பரவல் , கடுமையானது எடுப்போசை சுவாச , கடுமையானது எடுப்போசை சுவாச நோய்க்குறி ,